English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/128904
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

The safety of the use of bisphenol A in medical devices

Other TitlesSCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) Opinion on The safety of the use of bisphenol A in medical devices
AuthorsTestai, Emanuela; Hartemann, Philippe; Rodríguez-Farré, Eduard; Rastogi, Suresh Chandra; de Jong, Wim; Bustos, Juana; Castle, Laurence; Gundert-Remy, Ursula; Hensten, Arne; Kopperud, Hilde Molvig; Olea, Nicolás; Piersma, Aldert; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks)
KeywordsBisphenol A, risk assessment, safety, medical devices, SCENIHR
Issue Date18-Feb-2015
PublisherEuropean Commission
CitationThe safety of the use of bisphenol A in medical devices (2015)
AbstractThis opinion assesses whether the use of bisphenol A in medical devices such as implants, catheters, and dental devices could give reasons for safety concerns, to provide indications on limit values for BPA release from medical devices and to identify any patient group, e.g. infants, pregnant and breastfeeding women who would be particularly at risk. Several exposure scenarios have been evaluated taking into account the material used, information related to BPA leaching, the duration of a single treatment and the frequency of treatments, giving rise to toxicologically relevant acute, short and long term exposure. The SCENIHR concludes that risk for adverse effects of BPA may exist when the BPA is directly available for systemic exposure after non-oral exposure routes, especially for neonates in intensive care units, infants undergoing prolonged medical procedures and for dialysis patients. Although the benefit of medical devices has also to be considered, the SCENIHR recommends that, where practicable, medical devices that do not leach BPA should be used. The possibility of replacing BPA in these products should be considered against their efficiency in the treatment, as well as the toxicological profile of the alternative materials. However, better data on exposure would be beneficial for the refinement of the present risk assessment, to be carried out when new data on exposure via medical devices will be available.
DescriptionSCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Safety of the use of bisphenol A in medical devices, 18 February 2015
Testai, Emanuela; Hartemann, Philippe; Rodríguez-Farré, Eduard; Rastogi, Suresh Chandra; de Jong, Wim; Bustos, Juana; Castle, Laurence; Gundert-Remy, Ursula; Hensten, Arne; Kopperud, Hilde Molvig; Olea, Nicolás; Piersma, Aldert; SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). The Safety of the use of Bisphenol A in medical devices. [S.l.]: European Commission, 2015. 166 p. ISSN 1831-4783 . ISBN 978-92-79-30133-9 . DOI Doi: 10.2772/75546
Publisher version (URL)http://dx.doi.org/10.2772/75546
http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_040.pdf
URIhttp://hdl.handle.net/10261/128904
DOI10.2772/75546
Identifiersdoi: 10.2772/75546
issn: 1831-4783
isbn: 978-92-79-30133-9
Appears in Collections:(IIBB) Libros y partes de libros
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.